Collagen sponges for bone regeneration with rhBMP-2.
暂无分享,去创建一个
[1] Ralph Müller,et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.
[2] T. Zdeblick,et al. Is INFUSE Bone Graft Superior to Autograft Bone? An Integrated Analysis of Clinical Trials Using the LT-CAGE Lumbar Tapered Fusion Device , 2003, Journal of spinal disorders & techniques.
[3] C. Dickman,et al. Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages , 2002, Journal of spinal disorders & techniques.
[4] I. Heschel,et al. Impact of sterilization on the porous design and cell behavior in collagen sponges prepared for tissue engineering. , 2002, Biomaterials.
[5] K. Takaoka,et al. Effect of phosphodiesterase inhibitor-4, rolipram, on new bone formations by recombinant human bone morphogenetic protein-2. , 2002, Bone.
[6] J. Michael Kabo,et al. Histologic Evaluation of the Efficacy of rhBMP-2 Compared With Autograft Bone in Sheep Spinal Anterior Interbody Fusion , 2002, Spine.
[7] S. T. Yoon,et al. Osteoinductive Molecules in Orthopaedics: Basic Science and Preclinical Studies , 2002, Clinical orthopaedics and related research.
[8] H. Seeherman,et al. Recombinant Human Bone Morphogenetic Protein-2 Accelerates Healing in a Rabbit Ulnar Osteotomy Model , 2001, The Journal of bone and joint surgery. American volume.
[9] J. Wozney,et al. Delivering on the promise of bone morphogenetic proteins. , 2001, Trends in biotechnology.
[10] Freddie H. Fu,et al. Effect of Bone Morphogenetic Protein-2-Expressing Muscle-Derived Cells on Healing of Critical-Sized Bone Defects in Mice , 2001, The Journal of bone and joint surgery. American volume.
[11] H. Uludaǧ,et al. Engineering temperature-sensitive poly(N-isopropylacrylamide) polymers as carriers of therapeutic proteins. , 2001, Biotechnology and bioengineering.
[12] J. Wozney,et al. Delivery Systems for BMPs: Factors Contributing to Protein Retention at an Application Site , 2001, The Journal of bone and joint surgery. American volume.
[13] P. Boyne,et al. Application of Bone Morphogenetic Proteins in the Treatment of Clinical Oral and Maxillofacial Osseous Defects , 2001, The Journal of bone and joint surgery. American volume.
[14] H. Seeherman,et al. Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: A comparison of rhBMP‐2, cancellous bone graft, and absorbable collagen sponge , 2001, Journal of Orthopaedic Research.
[15] H. Seeherman,et al. The effect of recombinant human bone morphogenetic protein‐2 on femoral reconstruction with an intercalary allograft in a dog model , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[16] U. Ripamonti,et al. Transforming Growth Factor-β Supports the Rapid Morphogenesis of Heterotopic Endochondral Bone Initiated by Human Osteogenic Protein-1 via the Synergistic Upregulation of Molecular Markers , 2001, Growth factors.
[17] K. Bessho,et al. Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2. , 2000, The British journal of oral & maxillofacial surgery.
[18] K. Burg,et al. Biomaterial developments for bone tissue engineering. , 2000, Biomaterials.
[19] J Bonadio,et al. Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. , 2000, Advanced drug delivery reviews.
[20] C. Kirker-Head,et al. Potential applications and delivery strategies for bone morphogenetic proteins. , 2000, Advanced drug delivery reviews.
[21] C. Sfeir,et al. Gene therapy approaches for modulating bone regeneration. , 2000, Advanced drug delivery reviews.
[22] J. Fiorellini,et al. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. , 2000, Journal of periodontology.
[23] B. Nies,et al. Chemical and physicochemical characterization of porous hydroxyapatite ceramics made of natural bone. , 2000, Biomaterials.
[24] Antonios G. Mikos,et al. Growth Factor Delivery for Tissue Engineering , 2000, Pharmaceutical Research.
[25] S. Ludwig,et al. Osteoinductive bone graft substitutes , 2000, European Spine Journal.
[26] S. Boden,et al. The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.
[27] R. Sellers,et al. Repair of Articular Cartilage Defects One Year After Treatment with Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)* , 2000, The Journal of bone and joint surgery. American volume.
[28] S. Boden. Bioactive factors for bone tissue engineering. , 1999, Clinical orthopaedics and related research.
[29] S. Bruder,et al. Tissue engineering of bone. Cell based strategies. , 1999, Clinical orthopaedics and related research.
[30] H. Uludaǧ,et al. Characterization of absorbable collagen sponges as rhBMP-2 carriers. , 1999, International journal of pharmaceutics.
[31] J. Feijen,et al. Crosslinking and modification of dermal sheep collagen using 1, 4-butanediol diglycidyl ether. , 1999, Journal of biomedical materials research.
[32] H. Uludaǧ,et al. Bone regeneration with recombinant human bone morphogenetic protein-2 (rhBMP-2) using absorbable collagen sponges (ACS): influence of processing on ACS characteristics and formulation. , 1999, Pharmaceutical development and technology.
[33] R Peacock,et al. Ethylene oxide sterilization: the way ahead. , 1999, Medical device technology.
[34] J. Wozney,et al. rhBMP‐Collagen Sponges as Osteoinductive Devices: Effects of in Vitro Sponge Characteristics and Protein pI on in Vivo rhBMP Pharmacokinetics , 1999, Annals of the New York Academy of Sciences.
[35] M. Marone,et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. , 1999, Journal of spinal disorders.
[36] J. Fischgrund,et al. The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP‐2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion Model , 1999, Spine.
[37] I. Stockley,et al. Changes in allograft bone irradiated at different temperatures. , 1999, The Journal of bone and joint surgery. British volume.
[38] J. Wozney,et al. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. , 1998, Journal of biomedical materials research.
[39] William A. Pierce,et al. Effect of Recombinant Human Bone Morphogenetic Protein‐2 on Fracture Healing in a Goat Tibial Fracture Model , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] W. Sebald,et al. Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. , 1998, International journal of oral and maxillofacial surgery.
[41] Hollinger,et al. Sustained release emphasizing recombinant human bone morphogenetic protein-2. , 1998, Advanced drug delivery reviews.
[42] S. Omura,et al. A carrier for clinical use of recombinant human BMP-2: dehydrothermally cross-linked composite of fibrillar and denatured atelocollagen sponge. , 1998, International journal of oral and maxillofacial surgery.
[43] W. Friess,et al. Collagen--biomaterial for drug delivery. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[44] J. Wozney,et al. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. , 1997, The International journal of oral & maxillofacial implants.
[45] M. Zhang,et al. Effect(s) of the demineralization process on the osteoinductivity of demineralized bone matrix. , 1997, Journal of periodontology.
[46] E. Fu,et al. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. , 1997, Clinical oral implants research.
[47] E. Morris,et al. The Effect of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) on the Healing of Full-Thickness Defects of Articular Cartilage* , 1997, The Journal of bone and joint surgery. American volume.
[48] S. Boden,et al. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. , 1997, Journal of spinal disorders.
[49] J. Fiorellini,et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. , 1997, The International journal of periodontics & restorative dentistry.
[50] R. Marx,et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. , 1997, The International journal of periodontics & restorative dentistry.
[51] J. Wozney,et al. Periodontal repair in dogs: evaluation of rhBMP-2 carriers. , 1996, The International journal of periodontics & restorative dentistry.
[52] E. J. Miller,et al. Effect of physical crosslinking methods on collagen-fiber durability in proteolytic solutions. , 1996, Journal of biomedical materials research.
[53] P. Boyne. Animal studies of application of rhBMP-2 in maxillofacial reconstruction. , 1996, Bone.
[54] 淳博 木下,et al. Recombinant human bone morphogenetic protein-2 (rhBMP-2) の歯周組織に対する影響 , 1996 .
[55] C. Kirker-Head,et al. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2. , 1996, The International journal of periodontics & restorative dentistry.
[56] D. Butler,et al. Dose‐dependent response of gamma irradiation on mechanical properties and related biochemical composition of goat bone‐patellar tendon‐bone allografts , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[57] E. J. Miller,et al. Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment. , 1995, Journal of biomedical materials research.
[58] W. Hutton,et al. Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.
[59] J. Feijen,et al. Changes in the mechanical properties of dermal sheep collagen during in vitro degradation. , 1995, Journal of biomedical materials research.
[60] F. Noyes,et al. The effects of 4 Mrad of gamma irradiation on the initial mechanical properties of bone-patellar tendon-bone grafts. , 1994, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[61] J. Feijen,et al. Biocompatibility and tissue regenerating capacity of crosslinked dermal sheep collagen. , 1994, Journal of biomedical materials research.
[62] Y. Ikada,et al. Cross-Linking and Biodegradation of Native and Denatured Collagen , 1993 .
[63] Richard A. Kenley,et al. Biotechnology and Bone Graft Substitutes , 1993, Pharmaceutical Research.
[64] J. Kearney,et al. Evaluation of collagen cross‐linking techniques for the stabilization of tissue matrices , 1993, Biotechnology and applied biochemistry.
[65] H. Oppermann,et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. , 1992, The Journal of biological chemistry.
[66] A J Bailey,et al. Effect of chemical modifications on the susceptibility of collagen to proteolysis. II. Dehydrothermal crosslinking. , 1992, International journal of biological macromolecules.
[67] N. Perelman,et al. The effect of gamma-irradiation on collagen molecules, isolated alpha-chains, and crosslinked native fibers. , 1990, Journal of biomedical materials research.
[68] V. Rosen,et al. Novel regulators of bone formation: molecular clones and activities. , 1988, Science.
[69] V. Rosen,et al. Purification and characterization of other distinct bone-inducing factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[70] N. Dagalakis,et al. Design of an artificial skin. Part III. Control of pore structure. , 1980, Journal of biomedical materials research.
[71] M Chvapil,et al. Collagen sponge: theory and practice of medical applications. , 1977, Journal of biomedical materials research.
[72] R. W. Cox,et al. The effects of gamma irradiation on the structure and reactivity of native and cross-linked collagen fibres. , 1973, Journal of anatomy.
[73] F. Leonard,et al. Prolonged resorption of collagen sponges: Vapor‐phase treatment with formaldehyde , 1973 .
[74] M. Urist,et al. Bone: Formation by Autoinduction , 1965, Science.
[75] A. Bailey,et al. IRRADIATION-INDUCED CROSSLINKING OF COLLAGEN. , 1964, Radiation research.
[76] P. Tewes-Schwarzer. MANUFACTURING PRINCIPLES OF FREEZE-DRIED COLLAGEN SPONGES : CHARACTERISTICS AND APPLICATIONS , 1999 .
[77] J H Brekke,et al. Principles of tissue engineering applied to programmable osteogenesis. , 1998, Journal of biomedical materials research.
[78] V. Rosen,et al. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. , 1998, Clinical orthopaedics and related research.
[79] E. Khor. Methods for the treatment of collagenous tissues for bioprostheses. , 1997, Biomaterials.
[80] S. Vukicevic,et al. Regeneration of articular cartilage defects in rabbits by osteogenic protein-1 (bone morphogenetic protein-7). , 1997, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.
[81] J. Feijen,et al. In vitro degradation of dermal sheep collagen cross-linked using a water-soluble carbodiimide. , 1996, Biomaterials.
[82] W. Friess,et al. Basic thermoanalytical studies of insoluble collagen matrices. , 1996, Biomaterials.
[83] David Byrom. Biomaterials: Novel Materials from Biological Sources , 1991 .
[84] J. Swarbrick. Drugs and the pharmaceutical sciences , 1975 .